BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31460762)

  • 1. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells.
    Nycholat CM; Duan S; Knuplez E; Worth C; Elich M; Yao A; O'Sullivan J; McBride R; Wei Y; Fernandes SM; Zhu Z; Schnaar RL; Bochner BS; Paulson JC
    J Am Chem Soc; 2019 Sep; 141(36):14032-14037. PubMed ID: 31460762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
    Bochner BS
    Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
    Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
    Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
    Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
    Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7.
    Rillahan CD; Schwartz E; Rademacher C; McBride R; Rangarajan J; Fokin VV; Paulson JC
    ACS Chem Biol; 2013 Jul; 8(7):1417-22. PubMed ID: 23597400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways.
    Gonzalez-Gil A; Porell RN; Fernandes SM; Wei Y; Yu H; Carroll DJ; McBride R; Paulson JC; Tiemeyer M; Aoki K; Bochner BS; Schnaar RL
    Glycobiology; 2018 Oct; 28(10):786-801. PubMed ID: 29924315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewis
    Kroezen BS; Conti G; Girardi B; Cramer J; Jiang X; Rabbani S; Müller J; Kokot M; Luisoni E; Ricklin D; Schwardt O; Ernst B
    ChemMedChem; 2020 Sep; 15(18):1706-1719. PubMed ID: 32744401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.
    Hudson SA; Bovin NV; Schnaar RL; Crocker PR; Bochner BS
    J Pharmacol Exp Ther; 2009 Aug; 330(2):608-12. PubMed ID: 19458105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.
    Blixt O; Collins BE; van den Nieuwenhof IM; Crocker PR; Paulson JC
    J Biol Chem; 2003 Aug; 278(33):31007-19. PubMed ID: 12773526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
    Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
    J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
    Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
    Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialoside analogue arrays for rapid identification of high affinity siglec ligands.
    Blixt O; Han S; Liao L; Zeng Y; Hoffmann J; Futakawa S; Paulson JC
    J Am Chem Soc; 2008 May; 130(21):6680-1. PubMed ID: 18452295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
    Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
    Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.
    Tateno H; Li H; Schur MJ; Bovin N; Crocker PR; Wakarchuk WW; Paulson JC
    Mol Cell Biol; 2007 Aug; 27(16):5699-710. PubMed ID: 17562860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design.
    Attrill H; Takazawa H; Witt S; Kelm S; Isecke R; Brossmer R; Ando T; Ishida H; Kiso M; Crocker PR; van Aalten DM
    Biochem J; 2006 Jul; 397(2):271-8. PubMed ID: 16623661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E.
    Redelinghuys P; Antonopoulos A; Liu Y; Campanero-Rhodes MA; McKenzie E; Haslam SM; Dell A; Feizi T; Crocker PR
    J Biol Chem; 2011 Oct; 286(40):34522-32. PubMed ID: 21835922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
    Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
    Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.